Akumin Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Riadh Zine-El-Abidine
- Full Time Employees
- 1,737
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 8300 West Sunrise Boulevard Plantation FL United States of America 33322
- IPO Date
- Sep 3, 2020
- CIK
- 0001776197
- Website
- akumin.com
- Similar Companies
- Business
- Akumin Inc. Akumin Inc. is a leading provider of outpatient diagnostic imaging and radiation oncology services in the United States, operating through radiology and oncology segments that deliver advanced medical imaging and cancer treatment solutions to approximately 800 hospitals, health systems, and physician groups across 48 states. The company offers a comprehensive suite of radiology procedures, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic X-ray, fluoroscopy, and interventional radiology; its oncology services encompass radiation therapy and related treatments delivered via fixed-site outpatient centers, the nation's largest mobile imaging fleet, and Akumin AXIS relocatable clinics. Founded in 2015 and headquartered in Plantation, Florida, Akumin maintains a national network of over 180 owned or operated imaging locations and serves diverse customer types including hospitals and health systems with turn-key mobile and interim solutions emphasizing patient safety, operational efficiency, and technology integration. In recent developments, Akumin completed a deleveraging transaction in 2024 with Stonepeak, transitioning to a private company wholly owned by the firm through a prepackaged Chapter 11 process that strengthened its balance sheet, provided $130 million in new capital, and enhanced financial flexibility for growth; the company also announced a multi-year partnership with United Imaging in November 2024 and selected Lunit INSIGHT DBT AI technology in August 2025 to advance breast imaging accuracy nationwide, alongside receiving Vizient's Innovative Technology Designation.
Why Is Akumin (AKU) Stock Up 51% Today?
Akumin Inc. Reaches Agreement with Stonepeak to Become a Private Company
Akumin Inc. (AKU) Q2 2023 Earnings Call Transcript
Akumin Announces Change of Auditor
Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special Committee
Akumin to Host Second Quarter 2023 Financial Results Call on August 10, 2023
Why Is Akumin (AKU) Stock Up 31% Today?
Akumin Inc. (AKU) Q1 2023 Earnings Call Transcript
Akumin to Host Year-end 2022 Financial Results Call on March 17, 2023
Akumin Inc. (AKU) Q3 2022 Earnings Call Transcript
Akumin Inc.'s (AKU) CEO Riadh Zine on Q2 2022 Results - Earnings Call Transcript
Akumin to Host Second Quarter 2022 Financial Results Call on August 10, 2022
Akumin, Inc. (AKU) CEO Riadh Zine on Q1 2022 Results - Earnings Call Transcript
New Strong Sell Stocks for April 6th
New Strong Sell Stocks for April 4th
New Strong Sell Stocks for March 21st
Akumin Inc. to Present at the 40th Annual J.P. Morgan Health Care Conference
Akumin Investor Alert
Akumin Shareholder Alert
Akumin Investor Alert